After lengthy negotiations, the reform of EU genetic engineering legislation has almost reached the finish line. However, approval in the EU Parliament and Council cannot be taken for granted. Meanwhile, reactions to the agreement vary widely.
By Julia Dahm
The decisive round of negotiations in Brussels on the deregulation of new genomic techniques may be imminent. The German government is still holding back from a clear position. Proponents and opponents of liberalization are using the remaining time for their own interests.
By Julia Dahm
Shortly before the potentially decisive trilogue on a relaxation of EU genetic engineering legislation, skeptics and supporters are appealing to negotiators. Several German companies warn of the economic consequences of possible deregulation.
By Julia Dahm
After some delay, negotiations on relaxing EU genetic engineering legislation are continuing. However, important hurdles have not yet been overcome.
By Julia Dahm
